About Prosolia

Our Story

Prosolia is guided by the vision of democratizing the mass spectrometer, making the power of its measurements more accessible to scientists, clinicians and technicians. Our Desorption Electrospray Ionization (DESI) technology paved the way to achieving this vision with its invention in 2004 by a team led by Prof. R. Graham Cooks of Purdue University and included Dr. Zoltan Takats, a scientific founder, and Justin Wiseman, Prosolia’s Chairman, President & CEO. We launched our first DESI Molecular Imaging instrument in 2008 in the pharmaceutical industry and academia for a wide range of applications, including drug discovery and cancer research.  In 2014, we acquired the assets of QuantIon Technologies, a Purdue University spin-off, for the PaperSpray technology.  We commercialized the first PaperSpray device in 2015 as the Velox 360 for drug determination applications in forensic toxicology and pharmaceuticals.

Our Point of View

At Prosolia, we help our customers solve some of the most important problems in health and disease. We empower scientists in the pursuit of obtaining actionable molecular information for more accurate decisions in science and medicine. We do this by creating intuitive products that enhance and simplify the use of mass spectrometers, enabling new measurements, reducing complexity, and creating cost advantages for our customers to improve the outcomes for the lives we touch.

Our Technologies

Prosolia’s platforms simplify mass spectrometry allowing direct molecular analysis for disease phenotyping and drug determination in tissue, cells and biological fluids. These platforms accelerate breakthroughs in science and medicine by helping scientists deepen their understanding of disease biology, uncover new insights into drug action and distribution, and enable new measurements.

With more made possible in the lab, what more can you discover?

Our Products

Our Team

Our team is comprised of life sciences entrepreneurs who share a common vision of advancing science and helping patients through innovative laboratory technology. With decades of experience in mass spectrometry, diagnostics, and bioanalytical chemistry, and backed by a world-class team of academic partners, our team is uniquely suited to accelerate clinical research and diagnostics.

Justin Wiseman
Chairman, President & CEO
Justin is Chairman, President & CEO of Prosolia, Inc. He also serves on the Board of Directors of Phlebotics, Inc., a medical device company developing automated blood sampling systems for personalized care and is an Adjunct Professor of Chemistry and Chemical Biology at IUPUI in Indianapolis, IN. Justin joined Prosolia in 2007 as Director of Research and Development and was promoted to President & CEO in 2010. Justin was elected Chairman of the Company in January 2013. Justin is an author of over forty peer-reviewed scientific publications and book chapters accumulating over 5000 citations on the subject of mass spectrometry. He is an inventor on five patents and has presented invited lectures worldwide on ambient mass spectrometry. Prior to joining Prosolia, he obtained a Ph.D. in Analytical Chemistry from Purdue University under the guidance of Prof. R. Graham Cooks. During his tenure at Purdue University, Justin completed the Applied Management Principles Executive Education program at Krannert School of Management and was the recipient of Schering Plough’s Science and Innovation Award in 2006 for his work on the development and application of DESI. Prior to pursuing his doctoral studies at Purdue, Justin was an Analytical Chemist in Parenteral Quality Control at Eli Lilly and Company in Indianapolis, IN.
Read More... Read Less...
Brian Laughlin
Vice President, Engineering
Brian joined Prosolia in 2005 as a Senior Scientist and became Director of Product Development in 2008. Dr. Laughlin earned a Ph.D. in analytical chemistry at Purdue University in 2005, working under the guidance of Dr. R. Graham Cooks, Purdue's Henry Bohn Haas Distinguished Professor of Analytical Chemistry. His thesis research involved the design and construction of several mass spectrometers, including miniaturized and high throughput instruments. While at Purdue, Dr. Laughlin received fellowship support from numerous sources. He has published research results in several journals as well as presented at scientific conference
Read More... Read Less...
Raul Zavaleta
Vice President, Administration
Raul joined Prosolia in 2015 as an advisor and in 2016 became Vice President of Administration. Raul has over 25 years of national and international entrepreneurial experience leading emerging technology companies. He currently serves on the Board of Directors for Indigo Bioautomation and is on the Board of Trustees of Marion College in Indianapolis, Indiana. Prior to joining Prosolia, Raul was CEO of Indigo Bioautomation (www.indigobio.com) where he led Series A financing. He was CEO at Maaguzi, a developer of Patient Reported Outcomes for clinical trials where he led its growth and acquisition by PhaseForward/Oracle. Raul co-founded SciCor, a contract research organization, that later became Covance, one of the nation's largest CROs. Raul received a BS in Chemical Engineering from UCLA.
Read More... Read Less...
Greg Lyons
Director of Operations
Greg has been in the medical device industry for over 10 years. Greg began his career at Roche Diagnostics holding several positions in product development for diabetes care. After obtaining his master’s degree in Engineering Management he moved to Beckman Coulter as Instrument Manufacturing Supervisor. He joined Prosolia in 2012 as Manufacturing Manager and became Director of Operations in 2016. He built the Company’s overall operations strategy and continuously works on improving the Company’s production processes and supply chain controls. In his position, Greg oversees the day to day operations of Production, Supply Chain, Manufacturing Engineering and Purchasing and is responsible for improving operational efficiency, productivity and production costs in order to maximize gross margins. Greg received his BS degree in Biomedical Engineering and MS degree in Engineering Management from Rose-Hulman Institute of Technology in Terre Haute, Indiana. For his thesis project he developed a plan of transitioning from to push to pull supply chain methodology in a start-up environment.
Read More... Read Less...
Peter Kissinger
Peter Kissinger joined Prosolia in 2005 as interim CEO. Dr. Kissinger is the founder of Bioanalytical Systems, Inc., which he led from 1974-2007, and is a part time Professor of Chemistry at Purdue University, West Lafayette, Indiana. Dr. Kissinger received a B.S. in Chemistry (1966) from Union College, Schenectady, N.Y. and a Ph.D. in Analytical Chemistry (1970) from the University of North Carolina in Chapel Hill. Prior to joining the faculty at Purdue in 1975, Kissinger was a Research Associate at the University of Kansas (1970-1972) and an Assistant Professor at Michigan State University (1972-1975). He founded BASi in 1974. Headquartered in West Lafayette, Indiana, BASi manufactures instrumentation and develops software for pharmaceutical research, and carries out contract bioanalytical, pharmacological and toxicological research. Dr. Kissinger's academic research involved the development of modern liquid chromatography techniques and in vivo methodology for drug metabolism and the neurosciences. He has published more than 230 scientific papers and is a Fellow of the American Association of Pharmaceutical Scientists and the American Association for the Advancement of Science. In 2007, Dr. Kissinger and Candice Kissinger founded Phlebotics, Inc., a medical device company focused on diagnostic information for intensive care medicine.
Read More... Read Less...
Mike Alley
Mike Alley has served as a Director of the Company since September 2017.  Mike is chairman and owner of Patriot Investments, LLC, through which he maintains investment interests in multiple early stage companies and real estate investments.  He is active on multiple corporate boards including AAA Hoosier Motor Club, Banterra Bank and Banterra Corporation, Community Physicians Network, Johnson, Grossnickle +  Associates, and Falling Waters Farm, LLC. Mike formed Patriot Investments in 2002 to facilitate his personal investing activities.  Since that time, Patriot has provided investment capital to fourteen early stage companies and two more mature operating companies.  Patriot has primarily focused on Indiana based companies with innovative product offerings with high growth potential.  These have included investments in BioStorage Technologies, HC1, Prosolia, LiveLink, Scubaba and others. Mike served as Commissioner, Indiana Department of Revenue from 2012 through 2015 at the request of Governor Mitch Daniels and reappointment by Governor Mike Pence. During his tenure, Mike led the transformation of the Department to focus on quality and accuracy through multiple technology and cultural enhancements.  In addition, the Department became a nationally recognized leader in combating identity theft and tax refund fraud. Mike previously served as Chairman & CEO of Integra Bank Corporation in Evansville from 2008 through 2011 and President & CEO of Fifth Third Bank, Central Indiana in Indianapolis from 1989 through 2002. During the interim period, Mike was an active owner of two operating companies, electronic evolutions, inc., a leading electronics integrator, and Leaf Software Solutions, Inc., a leading software consulting company. Mike sold his interests to existing management teams in both of these operating companies.  Earlier in Mike’s career, he worked for Bank of America in Austin, Texas and KPMG in Cincinnati. Mike was successful in leading the entry of Fifth Third Bank into the Central Indiana marketplace beginning in 1989 with the purchase of The New Palestine Bank, a small community bank comprised of two banking offices and $45 million in assets.  During Mike’s tenure through 2002, Fifth Third grew to 74 banking offices and over $4.2 billion in assets with much of that coming from de novo and organic growth. Mike currently serves on several non-profit boards including the Indianapolis Zoo and Indiana State University Foundation.  He is a member of the American Institute of Certified Public Accountants, Indiana Society of CPA’s, Crooked Stick Golf Club, Palmetto Golf Club, and the Columbia Club.   Mike was graduated magna cum laude from Indiana State University in 1978 with a major in accounting. He is married to Amy Alley and they have one married daughter and two grandchildren. He enjoys golf, model railroading, gardening, reading, and traveling.
Read More... Read Less...
Rene Lewin
Rene Lewin has served as a Director of the Company since September 2017. Rene is a (retired) senior executive having held leadership positions at Wyeth as Sr. VP Human Resources and at Eli Lilly as President of Eli Lilly, Canada over a span of 38 years.  He currently is the Managing Director of RRL Capital, LLC which invests in start-ups focused on health care and medical devices.  Rene serves on the Dean’s Advisory Council for the Krannert School of Business and has taught Strategic Human Resources for General Managers at Purdue's Krannert School of Business MBA program.  Rene was recently recognized as the Distinguished Alumni of 2016 by the Krannert School of Business at Purdue University.
Read More... Read Less...
Our Collaborators

Prof. R. Graham Cooks
Prof. Cooks is the co-inventor of the DESI and PaperSpray® technology that is utilized in the DESI 2D and Velox 360 Prosolia products. Cooks has devoted decades to refining mass spectrometry tools. His team of researchers continues to improve efficiency, accuracy, and usability of mass spectrometry. He has been the recipient of over 60 honors and recognitions including the ALA Achievement Award from the Association for Laboratory Automation (2000), the Cotton Medal for Excellence in Chemical Research from the American Chemical Society (2012), the Outstanding Graduate Mentor Award from Purdue University (2011), and the Dreyfus Prize in the Chemical Sciences (2013). Additionally, Cooks has registered over 30 patents, authored over 10 books, and has served on the advisory board for several business entities, including Prosolia.
Read More... Read Less...
Prof. Zoltan Takats
Prof. Zoltan Takats is known as one of the chief founders of ambient mass spectrometry. He is a co-inventor of desorption electrospray ionization and the inventor of the iKnife. He has authored 78 peer-reviewed publications and is an original inventor of six mass spectrometric ionization techniques. In 2012, he moved to the United Kingdom where he currently serves as a Professor of Analytical Chemistry at Imperial College London. Additionally, Professor Takats was recognized with the prestigious Mattauch-Herzog Award of the German Mass Spectrometry Society. He was also granted the Hungarian Star Award for Outstanding Innovators.
Read More... Read Less...
Dr. Livia S. Eberlin
Dr. Livia S. Eberlin is a pivotal researcher in the development of DESI-MS. Her team developed a system that was successful in the rapid analysis and classification of brain tumors based on lipid information acquired by the DESI-MS. Dr. Eberlin was raised in Campinas, São Paulo, Brazil, and she began focusing on her passion for mass spectrometry in her undergraduate studies. Then in 2008, she began her Ph.D. program in Analytical Chemistry at Purdue University under the direction and mentorship of Prof. R. Graham Cooks. For her impactful contributions, Dr. Eberlin was given the Nobel Laureate Signature Award from the American Chemical Society, among other recognitions.
Read More... Read Less...
Prof. Richard Zare
Prof. Richard Zare is a key researcher for technologies that have led to the development of Prosolia products. His renowned research has resulted in greater understanding of chemical reactions at the molecular level. Through experimental and theoretical studies, his groundbreaking contributions have significantly contributed to knowledge of molecular collision processes as well as solving a variety of problems in chemical analysis. Prof. Zare has more than 50 patents, has authored and co-authored over 800 publications, and has published four books. He has been recognized with several awards and honors including the F. A. Cotton Medal for Excellence in Chemical Research (2009), and the King Faisal International Prize in Science (shared with George M. Whitesides) (2011), among numerous others.
Read More... Read Less...
Prof. Rick Yost
Prof. Yost is Head of the Analytical Chemistry Division at the University of Florida. He has served on the editorial boards of The Journal of the American Society for Mass Spectrometry and The International Journal of Mass Spectrometry. His research has included ninety-one graduate students funded by close to $4 million in research grants. Additionally, he has published over 155 papers. His research efforts have focused on analytical applications of tandem mass spectrometry and ion mobility, as well as instrumental developments and fundamental studies. His experiments, coupled with computer simulations of ion trajectories with SIMION, were instrumental in the successful completion of the Michigan State instrument. Following this and other patents for his research group, there have been $20 billion in mass spectrometers sold worldwide.
Read More... Read Less...
Prof. Kenneth Setchell
Prof. Kenneth Setchell is tenured faculty at the Department of Pediatrics at the University of Cincinnati College of Medicine at which he has served since 1984. He’s also served as the director of the Clinical Mass Spectrometry facility at Cincinnati Children’s Hospital Medical Center. His incredible work has significantly contributed to research through the development of chromatographic and mass spectrometry techniques for the isolation, purification, separation, identification, as well as measurement of bile acids, steroids, and phytoestrogens. In 2004, Setchell received the Adolf Windaus Prize for his research achievements in the sphere of bile acids and liver disease. In 1997, he was awarded the Gilbride award by the Canadian Liver Foundation. His leading research program in which he has collaborated with research groups from England, Italy, Germany, and other countries has also been internationally recognized. Additionally, Prof. Kenneth Setchell has served on national and international committees and editorial boards on international journals.
Read More... Read Less...
Prof. Gary Glish
Prof. Gary Glish serves as a faculty member in the department of chemistry at the University of North Carolina and has spent decades devoted to mass spectrometry research and development opportunities. Currently, Prof. Glish has collaborated on five patents—including an electrospray ionization device. He has contributed to over 132 peer-reviewed publications, including International Journal of Mass Spectrometry, the Journal of the American Society for Mass Spectrometry, and Analytical Chemistry. He has served as the President of the American Society for Mass Spectrometry, the Associate Editor of the Journal of the American Society for Mass Spectrometry, and on the editorial advisory board for Instrumentation Science and Technology.
Read More... Read Less...
Dr. Timothy Garrett
Dr. Timothy Garrett is the Research Assistant Professor in the Department of Pathology at the University of Florida where he develops new applications in clinical mass spectrometry. Additionally, he develops new imaging mass spec approaches to pathological specimens. Since 2009, Dr. Garrett has consulted nutraceutical, biotech, and pharmaceutical companies as the president and owner of Garrett Analytical Consulting, LLC. He works to develop new analytical methods, provides troubleshooting services, as well as technology application.
Read More... Read Less...
Dr. Nick Manicke
Dr. Nick Manicke has served as a lead developer for emerging mass spectrometry technologies, including the PaperSpray technology in the Velox 360 Prosolia product. He continues to work with researchers and industry representatives through his professional career with efforts supported by the National Science Foundation, the National Institutes of Health, and the National Cancer Institute. Dr. Manicke currently has several patents pending in relation to analytical chemistry equipment and processes. Additionally, he’s delivered a variety of presentations on analytical chemistry at conferences and workshops. He’s been published in several scholarly journals, including the Journal of the American Society for Mass Spectrometry, Analytical Chemistry, and Analyst. He’s been awarded numerous awards including the Young Investigator Travel Award.
Read More... Read Less...